Novel Medication Improves Ovarian Cancer Treatment

A new study appearing in International Journal of Gynecological Cancer states that Bevacizumab, a biologic anti-cancer agent that prevents tumor growth by interfering with the formation of new blood vessels, may have the potential to improve the efficacy of standard combination chemotherapy in ovarian cancer.

External Link: http://www.blackwellpublishing.com/press/pressitem.asp?ref=1...